Fevertree share price: where next ahead of its H1 earnings?
The maker of premium carbonated mixers is set to unveil its half-year (H1) results on 8 September, with the company delivering a resilient performance, reflected in its share price.
- Fevertree delivers resilient performance amid Covid-19, reflected in its share price
- Analysts at Barclays believe stock could hit £25 per share
- Fevertree confident it can deliver on its full-year 2020 outlook
Fevertree Drinks PLC is set to unveil its half-year (H1) results on 8 September, with the company delivering a relatively resilient performance despite the economic fallout from Covid-19, which has been reflected in its share price.
As it stands, the maker of premium carbonated mixers is trading 1% higher year-to-date, beating the broader market with the FTSE 100 still down 22% over the same period.
Investors are eager for an update on the company’s performance, with Fevertree’s stock capable of pushing to higher highs this year if it is able to deliver on its full-year 2020 outlook.
Analysts at Barclays believe stock could hit £25 per share
Analysts at Barclays are confident that the company will make good on its ambitions this year, with the bank reiterating its ‘overweight’ rating for the stock and issuing a target price of £25.
Based on Fevertree closing at £21.20 on Monday, analysts at Barclays believe the stock has a potential upside of 18%.
Fevertree confident it can deliver on FY20 outlook
The drinks maker had a solid start to the year, with trading in the first two months falling in-line with its expectations. However, from March onwards, trading across its regions was dominated by the economic fallout from Covid-19, leading to widespread closures of its on-trade business, though its off-trade channels continued to deliver a strong performance.
In fact, Fevertree’s off-trade revenues (sales occurring in supermarkets and convenience stores etc…) for the last 12 weeks to 14 June increased 34% year-on-year s the popularity of long mixed drinks as an everyday affordable treat continues to resonate with consumers.
‘As previously highlighted, the changes in channel and territory mix resulting from Covid-19 are expected to lead to gross margin headwinds during this financial year,’ Fevertree said.
‘However, we remain committed to our planned investments, particularly in marketing, and therefore intend to maintain our budgeted circa £60 million of operational costs for the full year, enabled by the group's strong balance sheet and conviction in our ability to deliver long-term sustainable growth.’
Acquisition of GDP crucial to optimise performance in Germany
Earlier this year, Fevertree announced its acquisition of Global Drinks Partnership (GDP), the group’s sales agent in Germany.
‘The completion of the GDP acquisition is an important step as we execute our growth plans in Germany, providing us with an ideal platform to take advantage of the opportunity within the German market and accelerate our growth,’ Fevertree CEO Tim Warrillow said.
‘I have worked closely with Morgan Zuill and his team at GDP since we first entered the German market and have been impressed with their approach and expertise in growing the Fever-Tree brand, so I am delighted that they are joining the Fever-Tree team,’ he added.
How to trade stocks with IG
- Create an IG trading account or log in to your existing account
- Enter ‘Fevertree Drinks PLC’ in the search bar and select it
- Choose your position size
- Click on ‘buy’ or ‘sell’ in the deal ticket
- Confirm the trade
This information has been prepared by IG, a trading name of IG Markets Limited. In addition to the disclaimer below, the material on this page does not contain a record of our trading prices, or an offer of, or solicitation for, a transaction in any financial instrument. IG accepts no responsibility for any use that may be made of these comments and for any consequences that result. No representation or warranty is given as to the accuracy or completeness of this information. Consequently any person acting on it does so entirely at their own risk. Any research provided does not have regard to the specific investment objectives, financial situation and needs of any specific person who may receive it. It has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such is considered to be a marketing communication. Although we are not specifically constrained from dealing ahead of our recommendations we do not seek to take advantage of them before they are provided to our clients. See full non-independent research disclaimer and quarterly summary.
Act on share opportunities today
Go long or short on thousands of international stocks with spread bets and CFDs.
- Get full exposure for a comparatively small deposit
- Trade on spreads from just 0.1%
- Get greater order book visibility with direct market access
See opportunity on a stock?
Try a risk-free trade in your demo account, and see whether you’re on to something.
- Log in to your demo
- Take your position
- See whether your hunch pays off
See opportunity on a stock?
Don’t miss your chance – upgrade to a live account to take advantage.
- Trade a huge range of popular stocks
- Analyse and deal seamlessly on fast, intuitive charts
- See and react to breaking news in-platform
See opportunity on a stock?
Don’t miss your chance. Log in to take advantage while conditions prevail.
Live prices on most popular markets
You might be interested in…
Find out what charges your trades could incur with our transparent fee structure.
Discover why so many clients choose us, and what makes us a world-leading provider of spread betting and CFDs.
Stay on top of upcoming market-moving events with our customisable economic calendar.